We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$115B
AUM Growth
+$6.24B
Cap. Flow
+$1B
Cap. Flow %
0.87%
Top 10 Hldgs %
23.71%
Holding
4,165
New
247
Increased
1,898
Reduced
1,581
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 8.69%
3 Financials 8.53%
4 Industrials 6.69%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RENT
3751
Rent the Runway
RENT
$122M
$33.2K ﹤0.01%
+583
New +$40.8K
HLLY icon
3752
Holley
HLLY
$373M
$32.3K ﹤0.01%
+11,804
New +$30.2K
CIK
3753
Credit Suisse Asset Management Income Fund
CIK
$134M
$32.1K ﹤0.01%
12,504
-17,026
-58% -$45.6K
LCTX icon
3754
Lineage Cell Therapeutics
LCTX
$278M
$31.8K ﹤0.01%
21,173
+1,000
+5% +$1.4K
MKTW icon
3755
MarketWise
MKTW
$54.3M
$31.4K ﹤0.01%
849
POWW icon
3756
Outdoor Holding Co
POWW
$268M
$30.8K ﹤0.01%
15,620
-60,000
-79% -$124K
ET icon
3757
PUT
Energy Transfer Partners
ET
$71.7B
$30K ﹤0.01%
+2,500
New +$31.6K
PVLA
3758
Palvella Therapeutics
PVLA
$2.25B
$29.3K ﹤0.01%
375
ME
3759
DELISTED
23andMe Holding Co
ME
$27K ﹤0.01%
592
+19
+3% +$917
OPEN icon
3760
Opendoor
OPEN
$3.42B
$26K ﹤0.01%
15,254
-351
-2% -$578
IMH
3761
DELISTED
Impac Mortgage Holdings Inc.
IMH
$25.7K ﹤0.01%
+73,470
New +$25.7K
AIV
3762
CALL
Aimco
AIV
$378M
$25K ﹤0.01%
+5,000
New +$37.3K
ICAD
3763
DELISTED
iCAD Inc
ICAD
$24.2K ﹤0.01%
19,546
+1,000
+5% +$2.08K
OPFI icon
3764
OppFi
OPFI
$593M
$24.1K ﹤0.01%
11,737
-970
-8% -$2.04K
APTO
3765
DELISTED
Aptose Biosciences, Inc.
APTO
$23.7K ﹤0.01%
82
+3
+4% +$871
DWSN icon
3766
Dawson Geophysical
DWSN
$138M
$23.6K ﹤0.01%
14,593
RXT icon
3767
Rackspace Technology
RXT
$1.15B
$23.5K ﹤0.01%
12,497
-2,061
-14% -$5.3K
ESPR
3768
DELISTED
Esperion Therapeutics
ESPR
$22.8K ﹤0.01%
14,338
-23,590
-62% -$122K
DHY
3769
Credit Suisse High Yield Credit Fund
DHY
$242M
$22.7K ﹤0.01%
12,000
EGLX
3770
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$22.2K ﹤0.01%
38,231
-250
-0.6% -$170
FRBK
3771
DELISTED
Republic First Bancorp Inc
FRBK
$22.1K ﹤0.01%
+16,250
New +$31.9K
GIS icon
3772
PUT
General Mills
GIS
$19.9B
$22K ﹤0.01%
+400
New +$31.9K
FTH
3773
Faeth Therapeutics
FTH
$771M
$21K ﹤0.01%
700
-250
-26% -$7.41K
SGTX
3774
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$20.8K ﹤0.01%
+1,723
New +$17.9K
IMPL
3775
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$20.3K ﹤0.01%
14,500

Similar funds

Raymond James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James & Associates held 4,165 positions worth $115B, up 5.7% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2023 filing shows 247 new, 1,898 increased, 1,581 reduced and 296 closed positions. Its largest new stake was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2023 buy was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $413M increase.
  • Raymond James & Associates's biggest Q1 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $18.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $115B portfolio in Q1 2023.
  • Raymond James & Associates opened 247 new positions and closed 296 in Q1 2023.
  • Raymond James & Associates's portfolio value rose 5.7% quarter-over-quarter to $115B.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.